Cytogen Corporation
Recent reports from Cytogen Corporation provided an update
Published in Medical Verdicts and Law Weekly, July 26th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Cytogen Corporation.
Report 1: Cytogen Corporation (NASDAQ: CYTO) reported updated data from a Phase 1 dose escalation study evaluating QUADRAMET(R) (samarium Sm-153 lexidronam injection) in combination with bortezomib (Velcade(R), Millennium Pharmaceuticals, Inc.) in patients with relapsed multiple myeloma. Data from 33 patients were presented today in a poster titled, "Phase 1 Trial of Bortezomib (Vel) and Samarium (Sam) in Multiple Myeloma," by James Berenson, M.D., Medical & Scientific...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- Allsup Inc.
Allsup Examines Impact of Social Security Taxes on Disabled and their Families - American Council of Life Insurers
ACLI Annual Conference Will Bring Life Insurance Industry Leaders to Washington, D.C. This Fall - American Life League
Law Evicts Planned Parenthood From Schools; a Noteworthy Victory for Parents in Missouri - Amistaff Healthcare Technology, Inc.
Amistaff Healthcare Technology, Inc. Announces a New Exam Validation Process to Improve the Quality of Patient Care - Antares Pharma
Antares Pharma Announces Closing of $16 Million Private Placement - AuthorHouse
'Murder Without Death': Small-Town Doctor Narrates His Fight Against Corruption - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
